First batch of Johnson & Johnson Covid vaccines arrive in Netherlands
NL TimesThe first 79,200 doses of a vaccine developed in Leiden by Janssen, a pharmaceutical firm owned by Johnson and Johnson, arrived at a warehouse in Oss on Monday. The Dutch Health Council recommends that Janssen's vaccine is first given to people over 60 and those from groups at high-risk of developing serious symptoms from Covid-19. The Janssen vaccine offers 66 percent protection against the disease and 85 percent protection against more severe forms of Covid-19, the disease caused by the coronavirus. The European Medicines Agency said there have been four reports of people who developed blood clots and low platelet counts after being given the Janssen jab. The American regulator reported on Friday that someone who received the Janssen vaccine died and suffered from the same condition of blood clots accompanied by a low platelet count that occurred with the AstraZeneca vaccine.